Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-678
Closed -$222K 251
2025
Q4
$222K Sell
678
-35
-5% -$11.1K 0.02% 243
2025
Q3
$201K Buy
+713
New +$207K 0.02% 267
2021
Q2
Sell
-1,451
Closed -$361K 158
2021
Q1
$361K Buy
1,451
+116
+9% +$27.7K 0.04% 170
2020
Q4
$307K Buy
1,335
+173
+15% +$39.9K 0.04% 177
2020
Q3
$295K Buy
1,162
+309
+36% +$76.6K 0.04% 166
2020
Q2
$201K Buy
+853
New +$195K 0.03% 197
2019
Q3
Sell
-1,303
Closed -$240K 228
2019
Q2
$240K Sell
1,303
-2
-0.2% -$358 0.03% 210
2019
Q1
$248K Sell
1,305
-213
-14% -$40.7K 0.04% 204
2018
Q4
$295K Buy
1,518
+213
+16% +$41.6K 0.05% 178
2018
Q3
$270K Sell
1,305
-90
-6% -$17.7K 0.04% 195
2018
Q2
$257K Sell
1,395
-27
-2% -$4.78K 0.04% 207
2018
Q1
$242K Sell
1,422
-93
-6% -$17.1K 0.04% 212
2017
Q4
$263K Sell
1,515
-631
-29% -$112K 0.05% 201
2017
Q3
$400K Sell
2,146
-17
-0.8% -$3.01K 0.08% 159
2017
Q2
$373K Sell
2,163
-91
-4% -$14.8K 0.08% 163
2017
Q1
$370K Buy
2,254
+32
+1% +$5.32K 0.08% 164
2016
Q4
$325K Buy
2,222
+262
+13% +$39.4K 0.07% 173
2016
Q3
$327K Buy
+1,960
New +$331K 0.07% 164

Other funds holding AMGN

Vicus Capital's AMGN Position: Q1 2026 in Review

Vicus Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 678 shares — an estimated $222K sold.

Vicus Capital first reported a position in AMGN in Q3 2016 and held it in 18 quarters. The position peaked at $400K in Q3 2017. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Vicus Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Vicus Capital sold 678 Amgen shares in Q1 2026, an estimated $222K.
  • Vicus Capital first reported a position in Amgen in Q3 2016 and held it in 18 quarters.
  • Vicus Capital's Amgen position peaked at $400K in Q3 2017.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Vicus Capital's 13F filing for Q1 2026, filed 22 Apr 2026.